Skip to main content
. 2020 Jul 2;21(13):4726. doi: 10.3390/ijms21134726
  • Adenylate succinase deficiency

  • Myotonic dystrophy

  • Angelman and Prader-Willi syndromes (AS–maternal or PWS–paternal 15q11-q13 deletions)

  • Neurofibromatosis

  • Apert syndrome

  • Noonan syndrome

  • 15q11.2 BP1-BP2 microdeletion (Burnside-Butler) syndrome

  • Oculo-auriculo-vertebral spectrum

  • CHARGE syndrome

  • Phelan-McDermid syndrome (22q13 deletion)

  • Chromosome 15 duplications (maternal origin)

  • PTEN gene associated disorders with extreme macrocephaly (Cowden/Bannayan-Riley-Ruvalcaba syndrome)

  • Chromosome 16p11.2 deletions

  • Rett syndrome (MECP2 gene)

  • Cohen syndrome

  • Shprinzten/velo-cardio-facial/DiGeorge

  • (22q11 deletion)

  • De Lange syndrome

  • Smith-Lemli-Opitz syndrome

  • Down syndrome

  • Smith-Magenis syndrome (17p11.2 deletion)

  • Duchenne muscular dystrophy

  • Sotos syndrome

  • Fragile X syndrome (FMR1 gene)

  • Tuberous sclerosis

  • Hypomelanosis of Ito

  • Turner syndrome

  • Joubert syndrome

  • Untreated or poorly treated phenylketonuria (PKU)

  • Mitochondrial dysfunction

  • Williams syndrome

  • Moebius sequence

Modified from G.B. Schaefer and N.J. Mendelsohn, “Genetics evaluation for the etiologic diagnosis of autism spectrum disorders,” Genetics in Medicine, vol. 10, pp 4–12, 2008 [25] and from M.G. Butler and others, “Assessment and treatment in autism spectrum disorders: A focus on genetics and psychiatry”, Autism Research and Treatment, vol. 2012, 242537, 2012 [30].